Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors

This paper describes the synthesis of a new class of peptidomimetic cysteine protease inhibitors based on a 1,4-benzodiazepine scaffold and on an electrophilic vinyl sulfone moiety. The former was introduced internally to a peptide sequence that mimics the fragment d-Ser-Gly; the latter was built on...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 51; no. 4; pp. 988 - 996
Main Authors Ettari, Roberta, Nizi, Emanuela, Di Francesco, Maria Emilia, Dude, Marie-Adrienne, Pradel, Gabriele, Vičík, Radim, Schirmeister, Tanja, Micale, Nicola, Grasso, Silvana, Zappalà, Maria
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 28.02.2008
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This paper describes the synthesis of a new class of peptidomimetic cysteine protease inhibitors based on a 1,4-benzodiazepine scaffold and on an electrophilic vinyl sulfone moiety. The former was introduced internally to a peptide sequence that mimics the fragment d-Ser-Gly; the latter was built on the P1-P1′ site and reacts as a classical “Michael acceptor”, leading to an alkylated enzyme by irreversible addition of the thiol group of the active site cysteine. The introduction of the vinyl sulfone moiety has been accomplished by olefin cross-metathesis, a powerful tool for the formation of carbon−carbon double bonds. New compounds 2–3 have been proven to be potent and selective inhibitors of falcipain-2, a cysteine protease isolated from Plasmodium falciparum, displaying antiplasmodial activity.
Bibliography:Experimental procedures for the synthesis of compound 10 and analytical data of final compounds 2 and 3. This material is available free of charge via the Internet at http://pubs.acs.org.
istex:7B3F6761F67490621584A9DF5E277F2250579C99
ark:/67375/TPS-K5Z7WKDX-S
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm701141u